[HTML][HTML] Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill …
DC Richter, O Frey, A Röhr, JA Roberts, A Köberer… - Infection, 2019 - Springer
Purpose Standard dosing and intermittent bolus application (IB) are important risk factors for
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a …
DC Richter, O Frey, A Röhr, JA Roberts, A Köberer… - Infection, 2019 - cabdirect.org
Purpose: Standard dosing and intermittent bolus application (IB) are important risk factors for
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a …
DC Richter, O Frey, A Röhr, JA Roberts, A Köberer… - …, 2019 - search.ebscohost.com
Purpose: Standard dosing and intermittent bolus application (IB) are important risk factors for
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a …
DC Richter, O Frey, A Röhr, JA Roberts, A Köberer… - …, 2019 - search.proquest.com
Purpose Standard dosing and intermittent bolus application (IB) are important risk factors for
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a …
DC Richter, O Frey, A Röhr, JA Roberts, A Köberer… - Infection, 2019 - infona.pl
Purpose Standard dosing and intermittent bolus application (IB) are important risk factors for
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a …
DC Richter, O Frey, A Röhr, JA Roberts… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Purpose Standard dosing and intermittent bolus application (IB) are important risk factors for
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a …
DC Richter, O Frey, A Röhr, JA Roberts, A Köberer… - 2019 - cabidigitallibrary.org
Purpose: Standard dosing and intermittent bolus application (IB) are important risk factors for
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a …
DC Richter, O Frey, A Röhr, JA Roberts, A Köberer… - Infection, 2019 - europepmc.org
Purpose Standard dosing and intermittent bolus application (IB) are important risk factors for
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
[PDF][PDF] Therapeutic drug monitoring‑guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill …
DC Richter, O Frey, A Röhr, JA Roberts, A Köberer… - Infection, 2019 - academia.edu
Purpose Standard dosing and intermittent bolus application (IB) are important risk factors for
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
[引用][C] Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill …
DC Richter, O Frey, A Röhr, JA Roberts… - …, 2019 - espace.library.uq.edu.au
Purpose: Standard dosing and intermittent bolus application (IB) are important risk factors for
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …